Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06324565
Other study ID # RC 24/2021
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 13, 2022
Est. completion date December 13, 2024

Study information

Verified date March 2024
Source IRCCS Burlo Garofolo
Contact Alessandro Boscarelli, MD
Phone +393931757607
Email alessandro.boscarelli@burlo.trieste.it
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Adnexal torsion is the fifth most common gynecologic emergency. Thirty percent of all cases of adnexal torsion occur in females younger than 20 years. Approximately 5 of 100,000 females aged 1-20 years are affected, with girls older than 10 years at increased risk because of hormonal influences and gonadal growth that result in an increased frequency of physiologic and pathologic masses. The most common clinical symptom of torsion is sudden-onset abdominal pain that is intermittent, non-radiating, and associated with nausea and vomiting in 62% and 67% of cases respectively. Moreover, abdominal tenderness is a clinical sign which is reported in up to 88% of patients with adnexal torsion. None of the following tests are useful in the diagnosis of adnexal torsion: leukocytosis, pyuria, C-reactive protein, and erythrocyte sedimentation rate. Actually, transabdominal ultrasonography is the imaging modality of choice with a sensitivity of 92% and specificity of 96% in detecting adnexal torsion. A second-line imaging tool in the diagnosis of adnexal torsion is magnetic resonance, which may require a sedation in selected cases. Consequently, there are no clinical or imaging criteria sufficient to confirm the preoperative diagnosis of adnexal torsion to date. Therefore, patients with a clinical suspicion for adnexal torsion should undergo emergent diagnostic laparoscopy.


Recruitment information / eligibility

Status Recruiting
Enrollment 130
Est. completion date December 13, 2024
Est. primary completion date December 13, 2024
Accepts healthy volunteers No
Gender Female
Age group N/A to 17 Years
Eligibility Inclusion Criteria: - Female patients - Age < 18 years - presenting with lower quadrants abdominal pain - Imaging suspicious for adnexal torsion Exclusion Criteria: - Female patients aged > 18 years - Previous surgery for adnexal pathologies - Clinical symptoms and imaging suggesting a different surgical pathology (i.e., appendicitis, gastroenteritis)

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
D-Dimer test
All patients in whom preoperative diagnostics have not been able to exclude a surgical pathology and who are candidates for diagnostic-therapeutic surgery will be referred for minimally invasive abdominal exploration in the real suspicion of ovarian torsion. During the pre-operative phase, blood exams will be performed including coagulation which will be integrated with the D-dimer values. In addition, as usual, the clinical examination of the patients will be performed integrated with the various diagnostic image tools generally used in this category of patients (abdomen ultrasound +/- magnetic resonance in urgency).

Locations

Country Name City State
Italy Institute for Maternal and Child Health - IRCCS "Burlo Garofolo" Trieste

Sponsors (1)

Lead Sponsor Collaborator
IRCCS Burlo Garofolo

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Diagnostic accuracy of the D-Dimer Area under the Receiver Operating Characteristic (ROC) curve (AUC) will be assessed to evaluate the diagnostic accuracy of the D-Dimer Through study completion, an average of 18 months
See also
  Status Clinical Trial Phase
Recruiting NCT05060120 - Biomarker Panel in Ovarian Torsion
Recruiting NCT01659489 - ADnexal TOrsion Markers Study N/A
Terminated NCT04522219 - Contribution of Contrast Enhanced Ultrasound in the Diagnosis of Adnexal Torsion Phase 3